Gorelick D A
Treatment Branch, National Institute on Drug Abuse, Baltimore, Maryland 21224.
Recent Dev Alcohol. 1993;11:413-27.
Neurobiological research over the past decade has greatly expanded our knowledge of alcohol's interaction with the nervous system and promises significant improvement in pharmacological treatment for all phases of alcoholism. Although no new treatment has yet become standard clinical practice, over the next decade benzodiazepine receptor antagonists and inverse agonists should improve treatment of acute alcohol intoxication, adrenergic agents and anticonvulsants should improve treatment of acute alcohol withdrawal, and serotonin uptake blockers and mu opiate receptor antagonists should improve long-term treatment of alcohol dependence. Future clinical research should reduce the current lack of knowledge on pharmacological treatment of alcoholism in special populations such as women, the elderly, and those with concurrent psychiatric diagnoses.
过去十年间,神经生物学研究极大地拓展了我们对于酒精与神经系统相互作用的认识,并有望显著改进针对酗酒各阶段的药物治疗。尽管尚无新的治疗方法成为标准临床实践,但在未来十年,苯二氮䓬受体拮抗剂和反向激动剂应能改善急性酒精中毒的治疗,肾上腺素能药物和抗惊厥药应能改善急性酒精戒断的治疗,5-羟色胺摄取阻滞剂和μ阿片受体拮抗剂应能改善酒精依赖的长期治疗。未来的临床研究应减少目前在特殊人群(如女性、老年人以及伴有精神疾病诊断者)酗酒药物治疗方面的知识欠缺。